Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3526 |
|
| Actual shortage: | 229 (6%) | |
| Anticipated shortage: | 3 (0%) | |
| Avoided shortage: | 11 (0%) | |
| Resolved: | 3283 (93%) | |
Discontinuation Reports |
366 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 342 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
143 (4%) |
|
Overdue reports |
32 (13%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-MODAFINIL | 100MG | TABLET | Resolved | 2024-10-24 | 2024-12-13 | 241084 |
| APO-MODAFINIL | 100MG | TABLET | Resolved | 2025-03-27 | 2025-04-04 | 253502 |
| APO-MOMETASONE | 50MCG | SPRAY, METERED DOSE | Resolved | 2017-07-17 | 2017-08-18 | 15959 |
| APO-MOMETASONE | 50MCG | SPRAY, METERED DOSE | Resolved | 2019-01-30 | 2019-02-01 | 74022 |
| APO-MOMETASONE | 50MCG | SPRAY, METERED DOSE | Resolved | 2020-10-28 | 2020-11-02 | 127367 |
| APO-MOMETASONE | 50MCG | SPRAY, METERED DOSE | Resolved | 2022-09-01 | 2022-09-15 | 168418 |
| APO-MOMETASONE | 50MCG | SPRAY, METERED DOSE | Resolved | 2023-06-29 | 2024-01-19 | 196946 |
| APO-MOMETASONE | 50MCG | SPRAY, METERED DOSE | Resolved | 2024-01-19 | 2024-05-22 | 216669 |
| APO-MONTELUKAST | 10MG | TABLET | Resolved | 2017-12-14 | 2018-02-15 | 32813 |
| APO-MONTELUKAST | 10MG | TABLET | Resolved | 2018-05-31 | 2018-10-05 | 50956 |
| APO-MONTELUKAST | 5MG | TABLET (CHEWABLE) | Resolved | 2018-08-09 | 2018-10-16 | 57792 |
| APO-MONTELUKAST | 5MG | TABLET (CHEWABLE) | Resolved | 2018-10-11 | 2018-10-16 | 63793 |
| APO-MONTELUKAST | 5MG | TABLET (CHEWABLE) | Resolved | 2019-01-15 | 2020-04-07 | 72357 |
| APO-MONTELUKAST | 10MG | TABLET | Resolved | 2019-03-13 | 2019-05-06 | 78529 |
| APO-MONTELUKAST | 10MG | TABLET | Resolved | 2019-09-18 | 2019-11-25 | 94171 |
| APO-MONTELUKAST | 4MG | TABLET (CHEWABLE) | Resolved | 2019-11-20 | 2020-04-07 | 99311 |
| APO-MONTELUKAST | 4MG | TABLET (CHEWABLE) | Resolved | 2020-05-13 | 2020-07-06 | 114949 |
| APO-MONTELUKAST | 5MG | TABLET (CHEWABLE) | Resolved | 2022-09-09 | 2022-12-05 | 169054 |
| APO-MONTELUKAST | 10MG | TABLET | Resolved | 2023-03-16 | 2023-03-30 | 187241 |
| APO-MONTELUKAST | 10MG | TABLET | Resolved | 2023-06-23 | 2023-08-04 | 196315 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-LOSARTAN/HCTZ | 25MG 100MG | TABLET | Discontinued | 2018-09-10 | 2018-12-28 | 60997 |
| APO-LOSARTAN/HCTZ | 12.5MG 100MG | TABLET | Discontinued | 2018-11-19 | 2018-11-19 | 67146 |
| APO-LOSARTAN/HCTZ | 12.5MG 50MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71101 |
| APO-MELOXICAM | 7.5MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60612 |
| APO-MEMANTINE | 10MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60615 |
| APO-METFORMIN | 500MG | TABLET | To be discontinued | 2018-02-23 | 2018-12-28 | 40781 |
| APO-METFORMIN | 500MG | TABLET | To be discontinued | 2018-02-23 | 2018-12-28 | 40784 |
| APO-METFORMIN | 500MG | TABLET | Discontinued | 2018-02-23 | 2018-11-26 | 40790 |
| APO-METFORMIN | 850MG | TABLET | Discontinued | 2018-02-23 | 2019-06-12 | 40778 |
| APO-METFORMIN | 850MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40796 |
| APO-METFORMIN ER | 500MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2019-01-04 | 2019-01-04 | 71207 |
| APO-METOCLOP TAB 10MG | 10MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1101 |
| APO-METOCLOP TAB 5MG | 5mg | tablet | Discontinued | 2017-03-13 | 2017-03-13 | 1105 |
| APO-METOPROLOL | 25MG | TABLET | To be discontinued | 2018-09-07 | 2021-06-03 | 60628 |
| APO-MYCOPHENOLATE | 250MG | CAPSULE | Discontinued | 2018-09-07 | 2018-09-15 | 60637 |
| APO-MYCOPHENOLATE | 500MG | TABLET | Discontinued | 2018-09-07 | 2018-10-12 | 60640 |
| APO-NAPRO-NA | 275MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60657 |
| APO-NAPRO-NA DS | 550MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60660 |
| APO-NAPROXEN | 250MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60666 |
| APO-NEVIRAPINE XR | 400MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2019-03-11 | 2019-03-11 | 78257 |